Congress·In Committee·H.R. 10212

To direct the Secretary of Veterans Affairs to study the potential benefits of peptide-based therapies for veterans receiving care through the Department of Veterans Affairs, and for other purposes.

2 days ago·View on Congress.gov

Next up: A house committee

A house committee must act next: committee consideration.

Legislative Progress

House

Senate

President

Law

Key Points

Full text not yet published

Congress hasn’t released the official text of this legislation yet. Once it’s published, this page will be updated with key points, impact assessments, and more.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.

Milestones

2 milestones2 actions

Sep 1, 2026House

Referred to the House Committee on Veterans' Affairs.

Sep 1, 2026

Introduced in House

The bill was officially filed and given a number. It now enters the legislative queue.

No votes, news coverage, or related bills recorded for this bill yet.

Source Information

Document Type

Congressional Bill

Bill NumberHR 10212

Congress119th Congress

ChamberHouse of Representatives

Latest ActionReferred to the House Committee on Veterans' Affairs.

Data Sources

Congress.gov

Official legislative information

Sponsor

Analysis generated by AI. Always verify with official sources.